SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001169245-23-000054
Filing Date
2023-11-15
Accepted
2023-11-15 16:17:16
Documents
5
Period of Report
2023-09-30
Effectiveness Date
2023-11-15

Document Format Files

Seq Description Document Type Size
1 NT 10-Q phasebio-nt10xqq32023.htm NT 10-Q 12146
2 phasebio-nt10xqq32023001.jpg GRAPHIC 108150
3 phasebio-nt10xqq32023002.jpg GRAPHIC 170715
4 phasebio-nt10xqq32023003.jpg GRAPHIC 284658
5 phasebio-nt10xqq32023004.jpg GRAPHIC 121536
  Complete submission text file 0001169245-23-000054.txt   957185
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-38697 | Film No.: 231410807
SIC: 2834 Pharmaceutical Preparations